US Map / Alabama

State AL

Clinical Trials in Alabama

Alabama is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Alabama and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials

199

Recruiting Now

199

← Back to US Map

Top Conditions in Alabama

Sickle Cell Disease (5)Breast Cancer (4)Multiple Myeloma (4)Pancreatic Ductal Adenocarcinoma (3)Kidney Calculi (3)Urolithiasis (3)Urolithiasis, Calcium Oxalate (3)Nephrolithiasis (3)Nephrolithiasis, Calcium Oxalate (3)Oxalate Urolithiasis (3)Healthy (3)Stroke (3)

Frequently Asked Questions — Clinical Trials in Alabama

How many clinical trials are currently recruiting in Alabama?

ClinicalMetric currently tracks 199 actively recruiting clinical trials with at least one location in Alabama. The total number of registered studies—including active but not currently enrolling trials—is 199. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.

What types of clinical trials are available in Alabama?

Alabama hosts clinical trials across a broad range of medical conditions, including Sickle Cell Disease, Breast Cancer, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Alabama serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.

How do I join a clinical trial near me in Alabama?

To join a clinical trial in Alabama, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Alabama maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Alabama

NCT07282886 Phase 2

VENTURI (VENTilation Using Respiratory Imaging)

University of Alabama at Birmi

NCT07206225 Phase 1

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Can...

Non-muscle Invasive Bladder Cancer

United States, France, Israel

NCT05671510 Phase 3

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhib...

Non Small Cell Lung Cancer

United States, Australia, Belgium

NCT06988618 N/A

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Seve...

Prurigo Nodularis

United States, Germany

NCT06595420 N/A

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

Cystic Fibrosis (CF)

University of Virginia

NCT07080242 Phase 1

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell L...

Small Cell Lung Cancer Metastatic or Locally Advanced

SystImmune Inc.

NCT06439082 Phase 3

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compar...

Sickle Cell Disease

United States, Brazil, Colombia

Novartis Pharmaceuticals

NCT04649242 Phase 3

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Pediatric Migraine

United States, Canada, China

NCT06602479 Phase 2

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo i...

United States, Czechia, Denmark

NCT06481306 Phase 1, Phase 2

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickl...

Anemia, Sickle Cell

United States, France, United Kingdom

Bristol-Myers Squibb

NCT05624450 Phase 3

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infec...

Viral Lung Infection and Acute Respiratory Failure

United States, Argentina, Australia

NCT05676476 N/A

The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensi...

University of Alabama at Birmi

NCT07041125 N/A

Concomitant LAAC/AF Ablation (Watchman FLX Pro)

PFA Ablation and LAAC Procedures

Heart Rhythm Clinical and Rese

NCT07102043 N/A

Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)

Cystic Fibrosis Related Diabetes

University of Alabama at Birmi

NCT07109869 Phase 3

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidia...

Vulvovaginal Candidiases

pH-D Feminine Health LLC

NCT06846320 Phase 2

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932...

Generalized Anxiety Disorder (GAD)

United States, Puerto Rico

NCT06911723 N/A

Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy...

Schizophrenia Disorders

University of Alabama at Birmi

NCT06980025 Phase 3

Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

Preterm Delivery

The George Washington Universi

NCT07285018 Phase 2

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With...

Diabetic Peripheral Neuropathic Pain

United States, Puerto Rico

Eli Lilly and Company

NCT06033924 N/A

Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

Peripheral Artery Disease

VA Office of Research and Deve

NCT05775159 Phase 2

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticance...

Hepatocellular Carcinoma

United States, China, Hong Kong

NCT06742996 Phase 3

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...

Mantle Cell Lymphoma

United States, Argentina, Australia

BeOne Medicines

NCT06925321 Phase 3

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult P...

Invasive Mold Infections

United States, Australia, Austria

Basilea Pharmaceutica

NCT05065216 Phase 2, Phase 3

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

United States, Belgium, Canada

DiaMedica Therapeutics Inc

NCT05128825 Phase 2

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Se...

High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

United States, Australia, Belgium

K-Group, Beta, Inc., a wholly

Page 3 of 8 — 199 trials total

← Prev Next →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology